Profile
Charles W.
Bishop is the founder of Proventiv Therapeutics LLC, which was founded in 2005.
He held the title of President from 2005 to 2006.
Dr. Bishop's former jobs include being the President, Chief Executive Officer & Director of Cytochroma, Inc. from 2012 to 2013, a Director at Receptor Therapeutics, Inc., and a Principal at Procter & Gamble Co. He was also the Chief Scientific Officer at Bone Care International, Inc. from 1987 to 2005.
Dr. Bishop's education includes an undergraduate degree from the University of Virginia and a doctorate from Virginia Polytechnic Institute & State University.
Former positions of Charles W. Bishop
| Companies | Position | End |
|---|---|---|
Cytochroma, Inc.
 Cytochroma, Inc. Pharmaceuticals: MajorHealth Technology Cytochroma, Inc. is a clinical-stage specialty pharmaceutical company. It develops and markets prescription products for the prevention of vitamin D insufficiency. The firm specializes in pharmaceutical products to treat and prevent secondary hyperparathyroidism associated with chronic kidney disease. The company was founded by Martin J. Petkovich in 1996 and is headquartered in Markham, Canada. | Chief Executive Officer | 2013-02-28 |
Proventiv Therapeutics LLC
 Proventiv Therapeutics LLC Pharmaceuticals: MajorHealth Technology Part of OPKO Health, Inc., Proventiv Therapeutics LLC is a company that develops vitamin D therapeutics. The company is based in Fitchburg, WI. The company was founded by Keith Crawford, Eric J. Messner, Charles W. Bishop. Proventiv Therapeutics was acquired by Cytochroma, Inc. on June 29, 2006. | Founder | 2006-05-31 |
Bone Care International, Inc.
 Bone Care International, Inc. Pharmaceuticals: OtherHealth Technology Bone Care International, Inc. developed innovative therapeutic products. Its products included Hectorol Injections and Capsules. The company was located in Middleton, WI. | Chief Tech/Sci/R&D Officer | 2005-05-31 |
Receptor Therapeutics, Inc.
 Receptor Therapeutics, Inc. BiotechnologyHealth Technology Receptor Therapeutics, Inc. was a bio-pharmaceutical company focused on in-licensing and developing anti-cancer therapies. The company was founded in 2007 and was headquartered in Toronto, Canada. | Director/Board Member | - |
| PROCTER & GAMBLE COMPANY | Corporate Officer/Principal | - |
Training of Charles W. Bishop
| University of Virginia | Undergraduate Degree |
| Virginia Polytechnic Institute & State University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PROCTER & GAMBLE COMPANY | Consumer Non-Durables |
| Private companies | 4 |
|---|---|
Cytochroma, Inc.
Cytochroma, Inc. Pharmaceuticals: MajorHealth Technology Cytochroma, Inc. is a clinical-stage specialty pharmaceutical company. It develops and markets prescription products for the prevention of vitamin D insufficiency. The firm specializes in pharmaceutical products to treat and prevent secondary hyperparathyroidism associated with chronic kidney disease. The company was founded by Martin J. Petkovich in 1996 and is headquartered in Markham, Canada. | Health Technology |
Bone Care International, Inc.
Bone Care International, Inc. Pharmaceuticals: OtherHealth Technology Bone Care International, Inc. developed innovative therapeutic products. Its products included Hectorol Injections and Capsules. The company was located in Middleton, WI. | Health Technology |
Proventiv Therapeutics LLC
Proventiv Therapeutics LLC Pharmaceuticals: MajorHealth Technology Part of OPKO Health, Inc., Proventiv Therapeutics LLC is a company that develops vitamin D therapeutics. The company is based in Fitchburg, WI. The company was founded by Keith Crawford, Eric J. Messner, Charles W. Bishop. Proventiv Therapeutics was acquired by Cytochroma, Inc. on June 29, 2006. | Health Technology |
Receptor Therapeutics, Inc.
Receptor Therapeutics, Inc. BiotechnologyHealth Technology Receptor Therapeutics, Inc. was a bio-pharmaceutical company focused on in-licensing and developing anti-cancer therapies. The company was founded in 2007 and was headquartered in Toronto, Canada. | Health Technology |
- Stock Market
- Insiders
- Charles W. Bishop
